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The fluorescent calcium indicator ‘quin2’ was used to demonstrate changes in cytoplasmic calcium 
concentrations in bovine anterior pituitary cells. The basal calcium concentration was 0.21 + 0.02pM 
(mean of 4 cell preparations). Thyroliberin (TRH) (10-‘“-10-6 M) rapidly and at the higher concentrations 
transiently increased the concentration. Dopamine (10-10-10-7 M) decreased the concentration transiently 
and more slowly. At lo-’ M, dopamine prevented the increase in calcium concentration caused by 10m9 M 
TRH, and partially inhibited the increase caused by higher concentrations of the peptide. The data support 
the hypothesis that calcium is the second messenger for TRH, and suggest hat dopamine inhibits TRH- 
induced prolactin secretion by preventing the calcium concentration from exceeding the level necessary to 
increase secretion. 
Anterior pituitary Cytoplasmic calcium Calcium concentration Dopamine Thyroliberin 
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1. INTRODUCTION 
The secretion of prolactin from the anterior 
pituitary is stimulated by TRH [l] and inhibited by 
dopamine [2]. Both effecters bind to the plasma 
membrane [3,4], and are therefore presumed to act 
through internal secondary messengers. Some data 
indicate that TRH increases and dopamine 
decreases pituitary cyclic nucleotide concentrations 
[ 1,5], although not all data support the suggestion 
that this mediates changes in hormone secretion 
[1,6]. Other data suggest that TRH increases 
[ 1,7-91 and dopamine decreases [6, lo] cytoplasmic 
calcium concentrations, but although the indirect 
evidence is generally accepted for TRH, the effect 
of dopamine is controversial [lo, 111. 
is added as quin2 acetoxymethyl ester which 
permeates the cells and is de-esterified within 
them. The de-esterified quin2, which cannot leak 
out of the cells, binds calcium with a Kd of 
0.115 PM (within the range expected for 
cytoplasmic calcium) and increases its fluorescence 
when bound to calcium. Thus changes in 
cytoplasmic calcium concentration are reflected in 
changes in quin2 fluorescence. This paper reports 
that the technique is applicable to pituitary cells 
and that TRH increases and dopamine decreases 
cytoplasmic calcium concentrations in them. 
2. MATERIALS AND METHODS 
The difficulty in deciding whether calcium is a 
second messenger in the anterior pituitary is in part 
due to the inaccessibility of cytoplasmic calcium to 
direct measurements in small cells. Recently a 
fluorescent dye, quin2, has been used as an inter- 
nal calcium indicator in lymphocytes [ 121. The dye 
2.1. Quin2 
Quin2 acetoxymethyl ester was obtained from 
Dr T.J. Rink of the Physiological Laboratory 
(Downing Street, Cambridge CB2 3EG). It was 
dissolved in dimethylsulphoxide at 20 mM, and 
stored at -20°C over desicant. 
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2.2. Incorporation of quin2 into pituitary cells 
Bovine anterior pituitary glands were dispersed 
and the cells centrifuged through Percoll as in [ 131. 
The pellet, enriched in lactotrophs and 
somatotrophs, was resuspended in the HEPES- 
buffered salt solution used for dispersion (contain- 
ing NaCl (131 mM), KC1 (6.0 n&I), KH2P04 
(1.2 mM), MgCl2 (0.24 mM), CaC12 (0.25 mM), 
sodium 3-hydroxybutyrate (1.2 mM), glucose 
(2.8 mM), bovine serum albumin (Sigma, fraction 
V, 1 mg/ml) and buffered with HEPES (20 mM) 
adjusted to pH 7.4 with NaOH). About 6 x 10’ 
cells were incubated for 60 min at 37°C in 6.5 ml 
of this buffer containing quin2 acetoxymethyl ester 
(30 M). The cells were then recovered by centri- 
fugation and resuspended in incubation buffer 
(identical to the dispersion buffer except that the 
concentrations of MgCl2 and CaC12 were 1.2 mM 
and 1 mM, respectively). The cell suspension was 
stored in ice until use. 
2.3. Measurement of quin2 fluorescence 
To measure the fluorescence of internal quin2 an 
aliquot of the cell suspension (4 x lo6 cells) was 
centrifuged briefly (1 s, Eppendorf 5412 centrifuge 
12000 x g), and resuspended in 3 ml incubation 
buffer at 37°C. This removed any quin2 leaked 
from the cells during storage on ice, which would 
affect the calibration procedure described below. 
If this precaution is taken, the basal calcium con- 
centration of the cells measured by fluorescence re- 
mains constant for at least 3 h. The fluorescence of 
the cell suspension was measured using 339 nm ex- 
citation and 490 mu emission [ 121, in a plastic 
cuvette maintained at 37°C and mixed either by a 
rotating paddle or by a magnetic stirrer. The 
fluorescence of the cells fell to a stable basal level 
within 5 min of warming the cells in the HEPES 
incubation buffer. 
The observed fluorescence (F&s) can be con- 
verted into an apparent calcium concentration by 
the calibration procedure in [ 121. Digitonin (20 ,uM 
final cont.) was added to lyse the cells and give the 
fluorescence when all the quin2 is saturated with 
calcium (&J, and EGTA (25 mM final cont., 
final pH 7.65) was added to give the fluorescence 
when all the quin2 is free (Fmin). The concentra- 
tions of free and calcium-bound quin2 which 
would give the observed fluorescence can then be 
calculated, and the calcium concentration can be 
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estimated using the Kd of quin2 for calcium [ 121. 
The addition of digitonin to unloaded cells causes 
a small increase in light scattering for which the 
values of Fmax and Z&, must be corrected before 
the calculations are made. This artefact can be 
avoided by careful selection of the excitation 
wavelength by double monochromators or by in- 
clusion of a Wratten 18B filter, and by using Barr 
and Stroud MS2 interference filters combined with 
Kodak Wratten no.2B filters to select emitted 
light. Under these conditions none of the hor- 
mones altered the fluorescence of unloaded cells. 
3. RESULTS 
Fig.1 shows the changes in fluorescence in 3 
cuvettes prepared from a single batch of cells. 
Fig.la shows that increasing the TRH concentra- 
tion in the cuvette in lo-fold increments from 
10-‘“-10-6 M increased the fluorescence of the 
loaded cells. The increases at low concentrations 
(1O-‘o-1O-8 M) were maintained but at high con- 
centrations (lo-’ and 10e6 M) they were transient, 
rising rapidly within the mixing time and falling 
over the next 2 min. 
Fig.lb shows that increasing the dopamine con- 
centration in a single cuvette by lo-fold increments 
from lo-” to lo-’ M caused the fluorescence of 
the internal quin2 to decrease. The fall in 
fluorescence caused by dopamine was slower than 
the rise after TRH, taking about 1 min to reach its 
nadir, and was transient especially at the lower 
dopamine concentrations. 
Fig.lc shows the effects of dopamine on the 
responses to TRH; in this cuvette dopamine was 
added at the higher concentration of 10e5 M, 
because we have previously found that this concen- 
tration blocks the stimulation of prolactin secre- 
tion by TRH (lo-’ M; [13]). Dopamine at lo-’ M 
caused a pronounced and prolonged fall in 
fluorescence. Subsequently, TRH at lo-” or 
10m9 M had little effect on the fluorescence but the 
peptide clearly increased fluorescence at lo-‘, lo-’ 
and 10T6 M, in the presence of dopamine. 
The experiments hown in fig.1 cannot be used 
to give dose-response relationships for TRH 
because the timing of the successive additions of 
TRH affects the peak responses. In fig.la, for ex- 
ample, the peak response to 10m6 M TRH was 
lower than that to lo-’ M, whereas in fig.lb the 
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Fig.1. The figure contains 3 chart recorder traces 
showing changes in fluorescence of quin2-loaded bovine 
pituitary cells. In each, the abscissa is increased 
fluorescence in arbitrary units and the ordinate is time; 
the inset bar in each panel represents 1 min. In fig.la, 
TRH was added at the times shown by the arrows to give 
final concentrations from the left of lo-“, 10e9, lo-*, 
lo-’ and low6 M. The rapid transient fall in fluorescence 
is an artefact caused by insertion of the injection needle 
into the light pathway. In fig.lb, dopamine was added 
at the times shown by the arrows to give final 
concentrations from the left of IO-“, 10e9, IO-* and 
10T7 M. In fig.lc, dopamine was added at the first 
arrow to bring the final concentration to 10e5 M, and 
then 5 successive additions of TRH added to give 
concentrations of lo-“, 10m9, lo-‘, lo-’ and 10e6 M. 
two responses were identical. In the latter case 
there was a shorter time lag between the two TRH 
additions so the fluorescence had less time to fall 
after the response to lo-’ M TRH. In other ex- 
periments, therefore, only one addition of TRH 
was made to each cuvette either in the presence or 
absence of dopamine (IO-’ M), and the maximum 
rise in calcium concentration determined. Fig.2 
shows that the basal calcium concentration was in- 
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Fig.2. The figure shows the effect of increasing TRH 
concentrations on the apparent cytoplasmic [Ca”] of 
quinZloaded pituitary cells in the absence (-t) or 
presence (-o-) of dopamine (10m5 M). Each point is 
the mean and the vertical bars SEM of 4 cell 
preparations. 
creased from 0.21 f 0.02 to 0.34 f 0.03 /IM by 
TRH (IO-’ M), and was decreased to 0.14 f 
0.01 ,uM by dopamine (10m5 M). Dopamine 
decreased the sensitivity of the system to TRH: in 
the absence of dopamine, TRH (10m9 M) increased 
the calcium concentration by 19 + 3.4% whereas in 
the presence of dopamine it had no effect. 
Dopamine also decreased the maximum response 
to TRH: in the presence of dopamine, TRH 
(lo-’ M) only increased the calcium concentration 
to 0.20 f 0.03 FM, a value not significantly dif- 
ferent from the basal level, of 0.21 + 0.02/M. 
4. DISCUSSION 
The data show that quin2 acetoxymethyl ester 
permeates pituitary cells and is hydrolysed within 
them, and that the fluorescence of intracellular 
quin2 responds to two physiological effecters of 
prolactin secretion, TRH and dopamine. The 
calculation of apparent calcium concentrations 
from the fluorescence assumes that the calcium 
81 
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concentration changes uniformly throughout the 
cytoplasm, and in all the cells in the suspension 
fI2]. This permits data from stimulated cells in dif- 
ferent experiments to be combined, bnt the values 
obtained probably do not have much physiological 
significance. In stimulated secretory cells calcium 
is probably non-uniformly distributed [ 141 and lac- 
totrophs but not somatotrophs in the cell disper- 
sion respond to TRH and dopamine under these 
conditions [13,15]. The calcium ~on~entr~t~on in 
restricted regions of lactotrophs probably changes 
more than the calculated values in fig.2 indicate. 
With this proviso, the data in fig.2 provide 
direct evidence that TRH at concentrations within 
the physiologist range increases cytoplasmic 
calcium concentrations. This confirms earlier in- 
direct evidence [7,9]. Both the secretory 113,151 
and the fluorescence responses to TRH are tran- 
sient. The transience of secretion could reflect the 
fluctuation in cytoplasmic calcium, possibly due to 
exhaustion of a rapidly releasable calcium pool 
since indirect evidence indicates TRH mobilizes in- 
ternally stored calcium I&16]. 
The data also show that dopamine at concentra- 
tions within the physiological range decreased the 
intracellular calcium concentration. This could ac- 
count for its ability to inhibit basal prolactin secre- 
tion f2,10], although the fact that the decrease in 
calcium was only transient whereas inhibition of 
secretion is sustained [2] rather complicates the in- 
terpretation. Dopamine at 10m5 M prevented the 
increase in calcium in response to IO-’ M TRH 
and decreased the response to higher TRH concen- 
trations. The cell dispersions used in this work con- 
tain both somatotrophs and lactotrophs, but lac- 
totrophs predominate since the ratio of the prolac- 
tin to growth hormone contents of the dispersions 
is 1.85 rt 0.16. However, in the presence of 
tetraethylammonium 1151 or a methyl~anthine 1131 
TRH can stimulate growth hormone secretion and 
dopamine fails to inhibit this stimulation [ 131. The’ 
rise in calcium seen at high TRH concentrations in 
the presence of dopamine could therefore occur in 
somatotrophs. Further purification of the cells is 
needed to determine whether this is so, but we have 
not observed any stimulatory effect of TRH on 
growth hormone secretion in the presence of 
10e5 M dopamine (unpublished) and have 
therefore no reason to suppose that TRH increases 
the calcium concentration in somatotrophs in the 
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presence of dopamine. Thus it is probable that 
dopamine inhibits prolactin secretion in response 
to TRH without completely preventing the rise in 
calcium in the lactotrophs. Either the calcium con- 
centration fails to reach the threshold necessary to 
increase secretion, or dopamine mnst prevent the 
action of calcium on the secretory pathway as sug- 
gested in flO,ll]. 
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